Charter Research

The trials here

What the 15 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease9 trials
• Fatty liver disease (MASLD/MASH)2 trials
• Parkinson disease2 trials
• Colorectal cancer1 trial
• COPD1 trial
• Liver cirrhosis1 trial
• Lung cancer1 trial
• Schizophrenia1 trial

Phase

• Phase 16 trials
• Phase 34 trials
• Phase 23 trials

Status

• Recruiting6 trials
• Active, not recruiting4 trials
• Not yet recruiting3 trials
• Completed2 trials

Lead sponsor

• Eli Lilly and Company5 trials
• Boehringer Ingelheim2 trials
• Eisai Inc.2 trials
• Freenome Holdings Inc.2 trials
• Gateway Institute for Brain Research1 trial
• and 3 more

Running trials

• Not yet recruiting

  A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)

  NCT07843459· Phase 1· Eli Lilly and Company· Source

  Contact: Jeffrey Norton (principal investigator)

• Recruiting

  A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's Disease

  NCT07787169· Phase 1· Eli Lilly and Company· Source

  Contact: Jeffrey Norton (principal investigator)

• Recruiting

  A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease

  NCT07787182· Phase 1· Eli Lilly and Company· Source

  Contact: Jeffrey Norton (principal investigator)

• Recruiting

  A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

  NCT06809400· Phase 1· Eli Lilly and Company· Source

  Contact: Jeffrey Norton (principal investigator)

• Active, not recruiting

  PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)

  NCT06750432· Phase 1· ProMis Neurosciences, Inc· Source

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease

  NCT06602258· Phase 2· Eisai Inc.· Source

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

  Contact: Jeffrey Norton, Site 1256

• Active, not recruiting

  A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

  NCT06544616· Phase 2· Janssen Pharmaceutica N.V., Belgium· Source

• Recruiting

  Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  NCT06122077· Freenome Holdings Inc.· Source

  Contact: Study Coordinator

• Recruiting

  Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

  NCT05266417· Phase 2· Gateway Institute for Brain Research· Source

  Contact: Alessandra Cuevas

• Active, not recruiting

  A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

  NCT03887455· Phase 3· Eisai Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease4 recruiting
• Fatty liver disease (MASLD/MASH)2 recruiting
• Parkinson disease2 recruiting
• COPD1 recruiting
• Liver cirrhosis1 recruiting
• Lung cancer1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants

  NCT04451408· Phase 1· Eli Lilly and Company· Source

• Completed

  Prevention of Colorectal Cancer Through Multiomics Blood Testing

  NCT04369053· Freenome Holdings Inc.· Source